​

Telomir Pharmaceuticals Ownership | Who Owns Telomir Pharmaceuticals?

OverviewFinancialsChart

Telomir Pharmaceuticals Ownership Summary

Telomir Pharmaceuticals is owned by 12.06% institutional investors, 34.17% insiders, and 53.78% retail investors.

TELO Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockTelomir Pharmaceuticals12.06%34.17%53.78%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20243815.15%3,565,51874.27%1225.25%3239.13%--100.00%
Sep 30, 20243332.00%2,045,931465.97%6463.57%234.55%5150.00%
Jun 30, 202425257.14%361,492352.33%11473.94%22214.29%2-
Mar 31, 20247-79,917---7---

TELO Ownership FAQ

Who Owns Telomir Pharmaceuticals?

Telomir Pharmaceuticals shareholders are primarily institutional investors at 12.06%, followed by 34.17% insiders and 53.77% retail investors. The average institutional ownership in Telomir Pharmaceuticals's industry, Biotech Stocks , is 68.48%, which Telomir Pharmaceuticals falls below.

Does Blackrock own Telomir Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Telomir Pharmaceuticals.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools